组织因子途径抑制剂与因子V水平之间的相互作用对静脉血栓形成风险的影响。 - Suppr

Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis.

作者信息

Dahm A E A, Bezemer I D, Sandset P M, Rosendaal F R

出版信息

J Thromb Haemost. 2010 May;8(5):1130-2. doi: 10.1111/j.1538-7836.2010.03805.x. Epub 2010 Feb 11.

DOI:10.1111/j.1538-7836.2010.03805.x

PMID:20149077

Abstract

摘要

相似文献

Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis.

J Thromb Haemost. 2010 May;8(5):1130-2. doi: 10.1111/j.1538-7836.2010.03805.x. Epub 2010 Feb 11.

The C-terminus of tissue factor pathway inhibitor α is required for its interaction with factors V and Va.

J Thromb Haemost. 2012 Sep;10(9):1944-6. doi: 10.1111/j.1538-7836.2012.04834.x.

Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.

Blood Coagul Fibrinolysis. 2007 Sep;18(6):559-64. doi: 10.1097/MBC.0b013e3281eec977.

Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism.

Thromb Haemost. 2005 Oct;94(4):787-90. doi: 10.1160/TH05-06-0412.

Factor V antigen levels and venous thrombosis: risk profile, interaction with factor V leiden, and relation with factor VIII antigen levels.

Arterioscler Thromb Vasc Biol. 2000 May;20(5):1382-6. doi: 10.1161/01.atv.20.5.1382.

The C536T transition in the tissue factor pathway inhibitor (TFPI) gene does not contribute to risk of venous thrombosis among carriers of factor V Leiden.

Thromb Haemost. 2000 Oct;84(4):724-5.

Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden.

Platelets. 2009 Sep;20(6):367-75. doi: 10.1080/09537100903096676.

Total and free levels of tissue factor pathway inhibitor: a risk factor in patients with factor V Leiden?

Blood Coagul Fibrinolysis. 1999 Mar;10(2):115-6. doi: 10.1097/00001721-199903000-00011.

Factor V Leiden paradox and the occurrence of distal vein thrombosis in a large cohort of thrombotic patients.

Thromb Res. 2017 Aug;156:20-22. doi: 10.1016/j.thromres.2017.05.025. Epub 2017 May 26.

Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis.

Thromb Haemost. 2010 Jun;103(6):1188-92. doi: 10.1160/TH09-08-0606. Epub 2010 Apr 29.

引用本文的文献

Platelet-Derived Factor V Is an Important Determinant of the Metastatic Potential of Circulating Tumor Cells.

Front Oncol. 2020 Sep 23;10:558306. doi: 10.3389/fonc.2020.558306. eCollection 2020.

Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.

Res Pract Thromb Haemost. 2018 Jan;2(1):93-104. doi: 10.1002/rth2.12058. Epub 2017 Dec 29.

Platelet-Derived Factor V Is a Critical Mediator of Arterial Thrombosis.

J Am Heart Assoc. 2017 Jul 3;6(7):e006345. doi: 10.1161/JAHA.117.006345.

Tissue factor pathway inhibitor: structure-function.

Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献